1. Home
  2. TARS vs CTRI Comparison

TARS vs CTRI Comparison

Compare TARS & CTRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • CTRI
  • Stock Information
  • Founded
  • TARS 2016
  • CTRI 1909
  • Country
  • TARS United States
  • CTRI United States
  • Employees
  • TARS N/A
  • CTRI N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • CTRI
  • Sector
  • TARS Health Care
  • CTRI
  • Exchange
  • TARS Nasdaq
  • CTRI Nasdaq
  • Market Cap
  • TARS 1.7B
  • CTRI 1.8B
  • IPO Year
  • TARS 2020
  • CTRI 2024
  • Fundamental
  • Price
  • TARS $69.09
  • CTRI $20.17
  • Analyst Decision
  • TARS Strong Buy
  • CTRI Hold
  • Analyst Count
  • TARS 7
  • CTRI 3
  • Target Price
  • TARS $67.14
  • CTRI $22.00
  • AVG Volume (30 Days)
  • TARS 737.2K
  • CTRI 2.3M
  • Earning Date
  • TARS 11-12-2025
  • CTRI 11-05-2025
  • Dividend Yield
  • TARS N/A
  • CTRI N/A
  • EPS Growth
  • TARS N/A
  • CTRI N/A
  • EPS
  • TARS N/A
  • CTRI N/A
  • Revenue
  • TARS $295,521,000.00
  • CTRI $2,711,264,000.00
  • Revenue This Year
  • TARS $137.28
  • CTRI $7.23
  • Revenue Next Year
  • TARS $42.84
  • CTRI $5.23
  • P/E Ratio
  • TARS N/A
  • CTRI N/A
  • Revenue Growth
  • TARS 254.45
  • CTRI 2.69
  • 52 Week Low
  • TARS $32.91
  • CTRI $14.46
  • 52 Week High
  • TARS $69.49
  • CTRI $24.60
  • Technical
  • Relative Strength Index (RSI)
  • TARS 77.06
  • CTRI 38.88
  • Support Level
  • TARS $56.25
  • CTRI $20.00
  • Resistance Level
  • TARS $59.78
  • CTRI $22.32
  • Average True Range (ATR)
  • TARS 2.58
  • CTRI 0.80
  • MACD
  • TARS 1.15
  • CTRI -0.20
  • Stochastic Oscillator
  • TARS 97.60
  • CTRI 4.15

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. It operates under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

Share on Social Networks: